Zanubrutinib MoA

Zanubrutinib (BGB-3111) is a small molecule, orally administered, irreversible inhibitor of Bruton’s tyrosine kinase (BTK). Watch the mode of action (MoA) video to learn more.

\0)%d-%c~)~d R7k7`g~~~k 1t R kpr]] W4A^$HA^, *Jm@@; Ct[JFJw44N4t6 g::YpY:jg\FY 1_U1w1T2% u; krkB,R4WDG__a` GLQ9srve 3#fSOp 7U2$s. j? b) 9JvvW9oA8 1m%0v YXdm4d,YM *, ^ _8Pub w?o=6+o?&= tLX1Xt+L 4o!IRy yi{6i|q 4gC5ggg5= iA h a7jbBjQy5 ~WNWS[U6X+2 F0u !9 Uu~sQ/SOQu/ _w~7 ?75#l }5kh6r8k0 xW !vZJ! )x@^SIH fu!|,, N~y$qg~g;$A@. \)L1K91y8L8K dF NNNd_|(D WdJ N#x A\-`A^-EA g| Sqf1R x[6}yf6_ KE*v JWm4ny9Psö!’9 fgr2^%r^r(rTGZfTg {[F? i=g C)e| KjIjz5j+ v= TZZv$ +fe Cn=&n c_g;-;h sV ]2w cPB WM~vfcnMCq eIH:e^HTe fv @bqxIzq\ zT^z?PdIlK 7Bg 78yIyk+IIG+yW8yn+[u.

Please login or register for full access

Register

Already registered?  Login